RxDoctor Payments Data

Caroline Campion

Child & Adolescent Psychiatry · New Orleans, LANPI 1528248671

Payments from drug & device makers

What this record shows

Janssen Research & Development, LLC accounts for 68.3% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $2,309, more than ten times the $14 reported in 2019.

$3,081in general payments, 2019–2025

Across 72 payments — averaging $42.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$2K
  • Ironshore Pharmaceuticals Inc.$187
  • Corium, LLC$141
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$125
  • Otsuka America Pharmaceutical, Inc.$107
  • AbbVie$94
  • plus $324 from 11 others
$770,970in research payments, 2019–2025

Across 58 payments — averaging $13,293 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Corium, LLC$531K
  • Janssen Research & Development, LLC$105K
  • Ironshore Pharmaceuticals Inc.$56K
  • Vanda Pharmaceuticals Inc.$51K
  • Collegium Pharmaceutical, Inc.$26K

What the payments were for

  • Travel & lodging$1,69055%
  • Food & beverage$1,39145%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,081 in reported general payments places this provider in the 85th percentile of 70 child & adolescent psychiatry providers in Louisiana.

See all child & adolescent psychiatry providers in Louisiana

Other child & adolescent psychiatry in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →